Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

The S&P 500 ended 0.2% higher on Monday, Jan. 13, 2025, ahead of this week's inflation data and the first wave of earnings ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...

Here are some of the biggest premarket US stock movers today: Macy’s (NYSE: M) stock fell 3.4% after the retailer said it ...

A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...

This morning, the Twenty-Second Statewide Grand Jury released its final report. This Grand Jury was tasked with investigating ...

Key Takeaways The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

NEW YORK — Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said ...

However, in July 2024, manufacturer Moderna halted its study because of concerns about severe side effects in a subset of infants aged 5-8 months. In this population, 12.5% of infants who received ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus ...